Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer Diagnosis
NCT03830619 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2021-11-22
Summary
The study is to investigate the sensitivity and specificity of serum exosome noncoding RNA as a biomarker for the diagnosis of lung cancer
Conditions
- Lung Cancer (Diagnosis)
Interventions
- DIAGNOSTIC_TEST
-
collect samples
collect serum samples and clinical features
Sponsors & Collaborators
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-01-01
- Primary Completion
- 2020-12-31
- Completion
- 2021-07-31
Countries
- China
Study Locations
More Related Trials
-
Whether Sputum Can Serve as an Alternative Source for Liquid Biopsy in Patients With Lung Cancer
NCT05034445 ·Status: COMPLETED
-
Development and Application of Molecular Evaluation Instrument for Lung Cancer Diagnosis and Treatment
NCT06086587 ·Status: NOT_YET_RECRUITING
-
Next-generation Sequencing of Small Cell Lung Cancer to Identify Susceptibility Gene and to Assess Treatment
NCT03244904 ·Status: UNKNOWN
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma
NCT03108677 ·Status: ACTIVE_NOT_RECRUITING
-
Detection Cell Free DNA in Lung Cancer Patients
NCT02738593 ·Status: UNKNOWN
-
Predictive Value of Exosomes in Pleural Effusion for Advanced Lung Cancer
NCT07262671 ·Status: ACTIVE_NOT_RECRUITING
-
Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer
NCT05742204 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients
NCT05023746 ·Status: COMPLETED
-
Clinical Study of ctDNA and Exosome Combined Detection to Identify Benign and Malignant Pulmonary Nodules
NCT04182893 ·Status: UNKNOWN
-
Epigenetic Nucleosomes in Plasma for Pulmonary Nodule Differentiation
NCT06838806 ·Status: RECRUITING
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage II to IIIA NSCLC by NGS
NCT03465241 ·Status: COMPLETED
-
Multiplex Analysis of Circulating Tumor DNA
NCT03301961 ·Status: UNKNOWN
-
A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer
NCT04254497 ·Status: COMPLETED
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
NCT03172156 ·Status: COMPLETED
-
The Role of DNA and RNA in NGS Analyses for Advaced Stage NSCLC Patients
NCT07188480 ·Status: RECRUITING ·Phase: NA
-
The Red Blood Cells Based Blood Test for Lung Cancer EARLY Detection
NCT05380999 ·Status: NOT_YET_RECRUITING
-
The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.
NCT03073902 ·Status: COMPLETED
-
NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy
NCT04636047 ·Status: UNKNOWN
-
Clinical Research for the Consistency Analysis of PD-L1 in Cancer Tissue and Plasma Exosome
NCT02890849 ·Status: COMPLETED ·Phase: NA
-
Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer
NCT05965024 ·Status: RECRUITING
-
Clinical Study for Combined Analysis of CTC and Exosomes on Predicting the Efficacy of Immunotherapy in Patients With Hepatocellular Carcinoma
NCT05575622 ·Status: UNKNOWN
-
ctDNA-MRD in Stage IIIB-C NSCLC Patients Treated With Induction Chemoimmunotherapy
NCT05822284 ·Status: NOT_YET_RECRUITING
-
Analysis of Plasma Tumor DNA in Lung Cancer Patients
NCT01930474 ·Status: UNKNOWN
-
Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan
NCT06358222 ·Status: RECRUITING